TrialFrontiers in immunology2025

Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 PROTECT clinical trial.

Abdul Abdellatif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.